Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 650 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100,712 | 112,864 |
| Total Cites | 1,311 | 1,359 |
| H-index | 18 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 72 | 73 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 336 | 352 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,143 | 1,164 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.17 |
| Self-Citation Percentage |
3.53%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 584 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94,845 | 104,177 |
| Total Cites | 1,345 | 1,408 |
| H-index | 16 | 17 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 80 | 83 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 257 | 273 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,120 | 1,145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
4.47%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 722 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107,635 | 107,181 |
| Total Cites | 1,296 | 1,393 |
| H-index | 17 | 18 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 82 | 95 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 167 | 201 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,071 | 1,095 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.27 |
| Self-Citation Percentage |
6.96%
|
|
Zhang, Zhiwen
Shanghai Institute of Materia Medica, Chinese Academy of Sciences,
China
2022 Rank: 94,799
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 636 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94,799 | 107,236 |
| Total Cites | 1,416 | 1,462 |
| H-index | 20 | 21 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 72 | 74 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 127 | 131 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,123 | 1,145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
3.15%
|
|
Zhang, Zhiwen
Shanghai Institute of Materia Medica, Chinese Academy of Sciences,
China
2021 Rank: 103,611
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 724 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103,611 | 114,972 |
| Total Cites | 2,175 | 2,277 |
| H-index | 25 | 25 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 118 | 126 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 164 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,724 | 1,762 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.29 |
| Self-Citation Percentage |
4.48%
|
|
Zhang, Zhiwen
Shanghai Institute of Materia Medica, Chinese Academy of Sciences,
China
2020 Rank: 109,017
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 707 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109,017 | 116,040 |
| Total Cites | 1,583 | 1,708 |
| H-index | 21 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 78 | 84 |
| Number of Single+First+Last Authored Papers | 21 | 21 |
| Total Cites to Single+First+Last Authored Papers | 89 | 103 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,292 | 1,335 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.28 |
| Self-Citation Percentage |
7.32%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.